These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17341489)

  • 21. Structure of the CLN3 gene and predicted structure, location and function of CLN3 protein.
    Mitchison HM; Taschner PE; Kremmidiotis G; Callen DF; Doggett NA; Lerner TJ; Janes RB; Wallace BA; Munroe PB; O'Rawe AM; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):12-4. PubMed ID: 9151311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction among Btn1p, Btn2p, and Ist2p reveals potential interplay among the vacuole, amino acid levels, and ion homeostasis in the yeast Saccharomyces cerevisiae.
    Kim Y; Chattopadhyay S; Locke S; Pearce DA
    Eukaryot Cell; 2005 Feb; 4(2):281-8. PubMed ID: 15701790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interaction between Sdo1p and Btn1p in the Saccharomyces cerevisiae model for Batten disease.
    Vitiello SP; Benedict JW; Padilla-Lopez S; Pearce DA
    Hum Mol Genet; 2010 Mar; 19(5):931-42. PubMed ID: 20015955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Strategy for mutation detection in CLN3: characterisation of two Finnish mutations.
    Munroe PB; O'Rawe AM; Mitchison HM; Järvelä IE; Santavuori P; Lerner TJ; Taschner PE; Gardiner RM; Mole SE
    Neuropediatrics; 1997 Feb; 28(1):15-7. PubMed ID: 9151312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic and biochemical analysis of the yeast plasma membrane Ssy1p-Ptr3p-Ssy5p sensor of extracellular amino acids.
    Forsberg H; Ljungdahl PO
    Mol Cell Biol; 2001 Feb; 21(3):814-26. PubMed ID: 11154269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The yeast model for Batten disease: a role for Btn2p in the trafficking of the Golgi-associated vesicular targeting protein, Yif1p.
    Chattopadhyay S; Roberts PM; Pearce DA
    Biochem Biophys Res Commun; 2003 Mar; 302(3):534-8. PubMed ID: 12615067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered gene expression in the eye of a mouse model for batten disease.
    Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. S. pombe btn1, the orthologue of the Batten disease gene CLN3, is required for vacuole protein sorting of Cpy1p and Golgi exit of Vps10p.
    Codlin S; Mole SE
    J Cell Sci; 2009 Apr; 122(Pt 8):1163-73. PubMed ID: 19299465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Moving towards therapies for juvenile Batten disease?
    Cooper JD
    Exp Neurol; 2008 Jun; 211(2):329-31. PubMed ID: 18400221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A disrupted homologue of the human CLN3 or juvenile neuronal ceroid lipofuscinosis gene in Saccharomyces cerevisiae: a model to study Batten disease.
    Guo WX; Mao C; Obeid LM; Boustany RM
    Cell Mol Neurobiol; 1999 Oct; 19(5):671-80. PubMed ID: 10384264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A murine model for juvenile NCL: gene targeting of mouse Cln3.
    Greene ND; Bernard DL; Taschner PE; Lake BD; de Vos N; Breuning MH; Gardiner RM; Mole SE; Nussbaum RL; Mitchison HM
    Mol Genet Metab; 1999 Apr; 66(4):309-13. PubMed ID: 10191119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Btn1 affects cytokinesis and cell-wall deposition by independent mechanisms, one of which is linked to dysregulation of vacuole pH.
    Codlin S; Haines RL; Burden JJ; Mole SE
    J Cell Sci; 2008 Sep; 121(Pt 17):2860-70. PubMed ID: 18697832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retinal pathology and function in a Cln3 knockout mouse model of juvenile Neuronal Ceroid Lipofuscinosis (batten disease).
    Seigel GM; Lotery A; Kummer A; Bernard DJ; Greene ND; Turmaine M; Derksen T; Nussbaum RL; Davidson B; Wagner J; Mitchison HM
    Mol Cell Neurosci; 2002 Apr; 19(4):515-27. PubMed ID: 11988019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X).
    Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M
    Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interaction with Btn2p is required for localization of Rsglp: Btn2p-mediated changes in arginine uptake in Saccharomyces cerevisiae.
    Chattopadhyay S; Pearce DA
    Eukaryot Cell; 2002 Aug; 1(4):606-12. PubMed ID: 12456008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene symbol: CLN3. Disease: Juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 May; 116(6):544. PubMed ID: 15991331
    [No Abstract]   [Full Text] [Related]  

  • 37. A feedback circuit between transcriptional activation and self-destruction of Gcn4 separates its metabolic and morphogenic response in diploid yeasts.
    Herzog B; Streckfuss-Bömeke K; Braus GH
    J Mol Biol; 2011 Jan; 405(4):909-25. PubMed ID: 21111745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype.
    Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA
    Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gene symbol: CLN3. Disease: juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Leman AR; Pearce DA; Rothberg PG
    Hum Genet; 2005 Feb; 116(3):236. PubMed ID: 15818814
    [No Abstract]   [Full Text] [Related]  

  • 40. Farnesylation of Batten disease CLN3 protein.
    Pullarkat RK; Morris GN
    Neuropediatrics; 1997 Feb; 28(1):42-4. PubMed ID: 9151320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.